Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Voriconazole for Oral Suspension [vor-i-KON-a-zole].
Voriconazole for Oral Suspension is indicated for the treatment of adults and pediatric patients 2 years of age and older with various yeast and fungal infections affecting various parts of the body, and in some cases, in patients intolerant of, or refractory to, other therapy.
For complete indications, click here.
Voriconazole for Oral Suspension is available in 40 mg/mL.
To learn more about this product, visit: Voriconazole for Oral Suspension
